The role of soluble intercellular adhesion molecules in neurodegenerative disorders
Abstract
Unlabelled Immunological disturbances have been implicated in the pathogenesis of some neurodegenerative disorders like Alzheimer's disease (AD) and amyotrophic lateral sclerosis (ALS). Adhesion molecules are markers of activated endothelial cells upregulated by action of cytokines.Materials and methods To investigate the activation or not of the vascular cells in AD and ALS, serum soluble intercellular adhesion molecule-1 (ICAM-1) and soluble E-selectin were evaluated (enzyme-like immunosorbent assay, ELISA) in 22 patients with Alzheimer's disease (AD), 20 patients with amyotrophic lateral sclerosis (ALS), 34 patients with non-inflammatory neurological diseases (NIND) and 15 control subjects.Results Patients with AD had higher s-ICAM-1 levels compared to NIND patients and control subjects (p<0.0027 and p<0.04, respectively). Patients with ALS had not higher s-ICAM-1 levels compared to NIND patients and control subjects (p<0.21 and p<0.31, respectively). Soluble-E-selectin levels in AD and ALS patients were not statistically different compared to NIND patients and controls (p<0.4, p<0.9 and p<0.3, p<0.19, respectively).Conclusions The presence of high s-ICAM values may be related to immunological processes involved in pathogenetic mechanisms of AD. The not statistically significant values of s-E selectin, a glycoprotein considered an exclusive marker of endothelial activation, seem to suggest the neural rather than the endothelial s-ICAM origin in patients with AD. The low values of s-ICAM-1 and sE-selectin in the serum of ALS patients do not exclude the presence of an unconventional immunological abnormality in this disorder.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Earlier investigations that have measured CSF and blood levels of ICAM-1, VCAM-1, and IL-15 in AD have produced conflicting results.
“Earlier investigations that have measured CSF and blood levels of ICAM-1, VCAM-1, and IL-15 in AD have produced conflicting results.38–42”
From CSF biomarkers of neuroinflammation and cerebrovascular dysfunction in early Alzheimer disease (2018) · cites this paper as [41]
Cites
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915 · see citing works
Rosen, D. R., Siddique, T., Patterson, D., Figlewicz, D. A., Sapp, P., Hentati, A., Donaldson, D., Goto, J., O'Regan, J. P., Deng, H.-X., et al. (1993) · Nature · doi:10.1038/362059a0 · Cited by 7,062 · see citing works
Román, G. C., Tatemichi, T. K., Erkinjuntti, T., Cummings, J. L., Masdeu, J. C., Garcia, J. H., Amaducci, L., Orgogozo, J.-M., Brun, A., Hofman, A., et al. (1993) · Neurology · doi:10.1212/wnl.43.2.250 · Cited by 4,921 · see citing works
Inflammation and Alzheimer’s disease
Akiyama, H. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00124-x · Cited by 4,514 · see citing works
Microglia: a sensor for pathological events in the CNS
Kreutzberg, G. W. (1996) · Trends in Neurosciences · doi:10.1016/0166-2236(96)10049-7 · Cited by 4,396 · see citing works
. Cerebral blood flow in dementia.
Hachinski, V. C., Iliff, L. D., Zilhka, E., Du Boulay, G. H., McAllister, V. L., Marshall, J., Russell, R. W. R., & Symon, L. (1975) · Archives of Neurology · doi:10.1001/archneur.1975.00490510088009 · Cited by 3,186 · see citing works
Baumann, H., & Gauldie, J. (1994) · Immunology Today · doi:10.1016/0167-5699(94)90137-6 · Cited by 2,907 · see citing works
Brooks, B. R. (1994) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(94)90191-0 · Cited by 2,144 · see citing works
Adams, R. D., & Victor, M. (1977) · Medical Entomology and Zoology · Cited by 1,718 · see citing works
MCGEER, P., & MCGEER, E. (1995) · Brain Research Reviews · doi:10.1016/0165-0173(95)00011-9 · Cited by 1,287 · see citing works
Identification of a Novel Aspartic Protease (Asp 2) as β-Secretase
Hussain, I., Powell, D., Howlett, D. R., Tew, D. G., Meek, T. D., Chapman, C., Gloger, I. S., Murphy, K. E., Southan, C. D., Ryan, D. M., et al. (1999) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.1999.0811 · Cited by 1,080 · see citing works
Rosen, D. (1993) · Nature · doi:10.1038/364362c0 · Cited by 922 · see citing works
A form of circulating ICAM-1 in human serum
Rothlein, R., Mainolfi, E. A., Czajkowski, M., et al. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.147.11.3788 · Cited by 690 · see citing works
Immunologic reactions in amyotrophic lateral sclerosis brain and spinal cord tissue.
Kawamata, T., Akiyama, H., Yamada, T., & McGeer, P. L. (1992) · PubMed Central · Cited by 546 · see citing works
(1994) · Toxicology and Industrial Health · doi:10.1177/074823379401000603 · Cited by 501 · see citing works
Brain macrophages: evaluation of microglia and their functions
Thomas, W. E. (1992) · Brain Research Reviews · doi:10.1016/0165-0173(92)90007-9 · Cited by 441 · see citing works
Atomic structure and chemistry of human serum albumin
He, X. M., & Carter, D. C. (1993) · Nature · doi:10.1038/364362b0 · Cited by 415 · see citing works
Alzheimer's disease. A double-labeling immunohistochemical study of senile plaques.
Dickson, D. W., Farlo, J., Davies, P., Crystal, H., Fuld, P. A., & Yen, S. H. (1988) · PubMed Central · Cited by 383 · see citing works
Cytokines, chemokines, and cytokine receptors in human microglia
Lee, Y. B., Nagai, A., & Kim, S. U. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10253 · Cited by 363 · see citing works
Strauss, S., Bauer, J., Ganter, U., Jonas, U., Berger, T., & Volk, B. (1992) · PubMed · Cited by 331 · see citing works
Acetylcholine receptors and myasthenia
Lindstrom, J. M. (2000) · Muscle & Nerve · doi:10.1002/(sici)1097-4598(200004)23:4 · Cited by 277 · see citing works
Itagaki, S., McGeer, P. L., & Akiyama, H. (1988) · Neuroscience Letters · doi:10.1016/0304-3940(88)90690-8 · Cited by 271 · see citing works
Vandenabeele, P., & Fiers, W. (1991) · Immunology Today · doi:10.1016/0167-5699(91)90032-o · Cited by 264 · see citing works
Novel Diagnostic Test for Acute Stroke
Lynch, J., Blessing, R., White, W. D., Grocott, H. P., Newman, M. F., & Laskowitz, D. T. (2003) · Stroke · doi:10.1161/01.str.0000105927.62344.4c · Cited by 248 · see citing works
Cell Mediators of Inflammation in the Alzheimer Disease Brain
Akiyama, H., Arai, T., Kondo, H., Tanno, E., Haga, C., & Ikeda, K. (2000) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-200000001-00008 · Cited by 238 · see citing works
Frohman, E. M., Frohman, T. C., Dustin, M. L., Vayuvegula, B., Choi, B. H., Gupta, A. A., van den Noort, S., & Gupta, S. (1989) · Journal of Neuroimmunology · doi:10.1016/0165-5728(89)90030-1 · Cited by 219 · see citing works
Latov, N., Hays, A. P., Donofrio, P. D., et al. (1988) · Neurology · doi:10.1212/wnl.38.5.763 · Cited by 184 · see citing works
Role of Inflammation in Stroke and Atherothrombosis
Chamorro, Á. (2004) · Cerebrovascular Diseases · doi:10.1159/000075297 · Cited by 173 · see citing works
Serum levels of circulating intercellular adhesion molecule 1 in human malignant melanoma.
Harning, R., Mainolfi, E. A., Bystryn, J. C., et al. (1991) · PubMed · Cited by 172 · see citing works
Vallet, P. G., Guntern, R., Hof, P. R., Golaz, J., Delacourte, A., Robakis, N. K. R. K., & Bouras, C. (1992) · Acta Neuropathologica · doi:10.1007/bf00308476 · Cited by 170 · see citing works
Microglia, Scavenger Receptors, and the Pathogenesis of Alzheimer’s Disease
Khoury, J. B. E., Hickman, S., Thomas, C. A., Loike, J. D., & Silverstein, S. C. (1998) · Neurobiology of Aging · doi:10.1016/s0197-4580(98)00036-0 · Cited by 157 · see citing works
Serum antibodies to GM 1 ganglioside in amyotrophic lateral sclerosis
Pestronk, A., Adams, R. N., Clawson, L., Cornblath, D. R., Kuncl, R. W., Griffin, D. E., & Drachman, D. B. (1988) · Neurology · doi:10.1212/wnl.38.9.1457 · Cited by 152 · see citing works
Akiyama, H., Kawamata, T., Yamada, T., Tooyama, I., Ishii, T., & McGeer, P. L. (1993) · Acta Neuropathologica · doi:10.1007/bf00334673 · Cited by 137 · see citing works
Motor neuron disease and amyotrophic lateral sclerosis
Younger, D. S., Rowland, L. P., Latov, N., et al. (1990) · Neurology · doi:10.1212/wnl.40.4.595 · Cited by 122 · see citing works
Evidence for autoimmunity in amyotrophic lateral sclerosis
Appel, S. H., Smith, R. G., Engelhardt, J. I., & Stefani, E. (1993) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(93)90106-9 · Cited by 121 · see citing works
Expression of intercellular adhesion molecule 1 (ICAM-1) in Alzheimer’s disease
Frohman, E. M., Frohman, T. C., Gupta, S., de Fougerolles, A., & van den Noort, S. (1991) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(91)90202-i · Cited by 120 · see citing works
Elevated serum levels of tumor necrosis factor‐α in Guillain‐Barré syndrome
Sharief, M. K., McLean, B., & Thompson, E. J. (1993) · Annals of Neurology · doi:10.1002/ana.410330606 · Cited by 116 · see citing works
Cellular immune response in multiple sclerosis plaques.
Boyle, E. A., & McGeer, P. L. (1990) · PubMed Central · Cited by 115 · see citing works
Serum and CSF immunological findings in ALS
Apostolski, S., Nikolić, J., Bugarski-Prokopljević, C., Miletić, V., Pavlović, S., & Filipović, S. (1991) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1991.tb04656.x · Cited by 114 · see citing works
Dore‐Duffy, P., Newman, W., Balabanov, R. D., Lisak, R. P., Mainolfi, E. A., Rothlein, R., & Peterson, M. G. E. (1995) · Annals of Neurology · doi:10.1002/ana.410370111 · Cited by 111 · see citing works
Circulating adhesion molecules and inflammatory mediators in demyelination
Hartung, H.-P., Archelos, J. J., Zielasek, J., et al. (1995) · Neurology · doi:10.1212/wnl.45.6_suppl_6.s22 · Cited by 111 · see citing works
(1994) · PubMed Central · Cited by 105 · see citing works
Appel, S. H. (1986) · Archives of Neurology · doi:10.1001/archneur.1986.00520030026007 · Cited by 105 · see citing works
Castillo, J., & Rodríguez, I. B. (2003) · Cerebrovascular Diseases · doi:10.1159/000074791 · Cited by 104 · see citing works
Amyotrophic lateral sclerosis is a multifactorial disease
Eisen, A. (1995) · Muscle & Nerve · doi:10.1002/mus.880180711 · Cited by 102 · see citing works
Degenerative Diseases of the Nervous System
Hankey, G., & Wardlaw, J. M. (2008) · CRC Press eBooks · doi:10.1201/b17272-18 · Cited by 94 · see citing works
Experimental autoimmune motoneuron disease
Engelhardt, J. I., Appel, S. H., & Killian, J. M. (1989) · Annals of Neurology · doi:10.1002/ana.410260310 · Cited by 79 · see citing works
Amyotrophic lateral sclerosis: An unconventional autoimmune disease?
Drachman, D. B., & Kuncl, R. W. (1989) · Annals of Neurology · doi:10.1002/ana.410260214 · Cited by 76 · see citing works
Jander, S., Heidenreich, F., & Stoll, G. (1993) · Neurology · doi:10.1212/wnl.43.9.1809 · Cited by 74 · see citing works
Shoji, M., Hirai, S., Yamaguchi, H., Harigaya, Y., Ishiguro, K., & Matsubara, E. (1991) · PubMed Central · Cited by 63 · see citing works
Immunological mechanisms and the spectrum of psychiatric syndromes in Alzheimer's disease
Eikelenboom, P., Hoogendijk, W. J. G., Jonker, C., & van Tilburg, W. (2002) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(02)00006-7 · Cited by 60 · see citing works
New Alzheimer's Therapy Suggested
Schnabel, J. (1993) · Science · doi:10.1126/science.8323582 · Cited by 57 · see citing works
Plasmapheresis With Immunosuppression in Amyotrophic Lateral Sclerosis
Kelemen, J., Hedlund, W., ORLIN, J. B., et al. (1983) · Archives of Neurology · doi:10.1001/archneur.1983.04050110070012 · Cited by 57 · see citing works
Tsukada, N., Miyagi, K., Matsuda, M., & Yanagisawa, N. (1993) · Annals of Neurology · doi:10.1002/ana.410330614 · Cited by 56 · see citing works
Evidence for autoimmunity in amyotrophic lateral sclerosis
Appel, S. H., Smith, R. G., Engelhardt, J. I., & Stefani, E. (1994) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(94)90171-6 · Cited by 53 · see citing works
Brown, R. H., Hauser, S. L., Harrington, H., & Weiner, H. L. (1986) · Archives of Neurology · doi:10.1001/archneur.1986.00520040063021 · Cited by 51 · see citing works
Plasmapheresis in amyotrophic lateral sclerosis
Olarte, M. R., Schoenfeldt, R. S., McKiernan, G., & Rowland, L. P. (1980) · Annals of Neurology · doi:10.1002/ana.410080625 · Cited by 51 · see citing works
Gammopathy with proximal motor axonopathy simulating motor neuron disease
Parry, G. J., Holtz, S. J., Ben-Zeev, D., et al. (1986) · Neurology · doi:10.1212/wnl.36.2.273 · Cited by 39 · see citing works
Degenerative diseases of the nervous system
Youdim, M. B. H. (2007) · Springer eBooks · Cited by 37 · see citing works
Antibodies from ALS patients inhibit dopamine release mediated by L-type calcium channels
Offen, D., Halevi, S., Orion, D., et al. (1998) · Neurology · doi:10.1212/wnl.51.4.1100 · Cited by 36 · see citing works
Neuropathy and motor neuron syndromes associated with plasma cell disease
Patten, B. M. (2009) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1984.tb00802.x · Cited by 32 · see citing works
Does Parkinson??s Disease Have an Immunological Basis?
Fiszer, U. (2001) · BioDrugs · doi:10.2165/00063030-200115060-00001 · Cited by 31 · see citing works
Motor neuron disease and paraproteinemia
Rudnicki, S. A., Chad, D. A., Drachman, D. A., et al. (1987) · Neurology · doi:10.1212/wnl.37.2.335 · Cited by 29 · see citing works
Oka, N., Akiguchi, I., Kawasaki, T., et al. (1994) · Annals of Neurology · doi:10.1002/ana.410350518 · Cited by 22 · see citing works
Oka, N., Akiguchi, I., Nagao, M., et al. (1994) · Neurology · doi:10.1212/wnl.44.5.946 · Cited by 22 · see citing works
Experimental immune-mediated motor neuron diseases: Models for human ALS
SMITH, R. G., Engelhardt, J. I., Tajti, J., & Appel, S. H. (1993) · Brain Research Bulletin · doi:10.1016/0361-9230(93)90268-g · Cited by 22 · see citing works
Trojano, M., Avolio, C., Ruggieri, M., et al. (1998) · Multiple Sclerosis Journal · doi:10.1177/135245859800400110 · Cited by 19 · see citing works
Ikeda, J., Kohriyama, T., & Nakamura, S. (2000) · European Journal of Neurology · doi:10.1046/j.1468-1331.2000.t01-1-00114.x · Cited by 17 · see citing works
Musso, A., Zanusso, G., Bonazzi, M. L., et al. (1994) · Neurological Sciences · doi:10.1007/bf02339236 · Cited by 17 · see citing works
Benatar, M. G., Offen, D., Mosberg, R., et al. (1999) · Cited by 7 · see citing works
Trojano, M., Avolio, C., Ruggieri, M., et al. (1998) · Multiple Sclerosis Journal · doi:10.1191/135245898678909204 · Cited by 7 · see citing works
Katchar, K., Osorio, L. M., Conradi, S., Wigzell, H., & Gigliotti, D. (2001) · Scandinavian Journal of Immunology · doi:10.1046/j.1365-3083.2001.00923.x · Cited by 6 · see citing works
Antibodies from ALS patients inhibit dopamine release mediated by L-type calcium channels
Benatar, M., Offen, D., Mosberg, R., et al. (1999) · Neurology · doi:10.1212/wnl.52.7.1517-e · Cited by 3 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
The blood-brain barrier in Alzheimer’s disease
Zenaro, E., Piacentino, G., & Constantin, G. (2017) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.07.007 · Cited by 767 · see citing works
CSF biomarkers of neuroinflammation and cerebrovascular dysfunction in early Alzheimer disease
Janelidze, S., Mattsson, N., Stomrud, E., Lindberg, O., Palmqvist, S., Zetterberg, H., Blennow, K., & Hansson, O. (2018) · Neurology · doi:10.1212/wnl.0000000000006082 · Cited by 359 · see citing works
Hu, Y., Cao, C., Qin, X.-Y., Yu, Y., Yuan, J., Zhao, Y., & Cheng, Y. (2017) · Scientific Reports · doi:10.1038/s41598-017-09097-1 · Cited by 183 · see citing works
Soluble adhesion molecules and angiotensin-converting enzyme in dementia
Nielsen, H. M., Londos, E., Minthon, L., & Janciauskiene, S. M. (2007) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.11.011 · Cited by 80 · see citing works
Rentzos, M., Zoga, M., Paraskevas, G. P., Kapaki, E., Rombos, A., Nikolaou, C., Tsoutsou, A., & Vassilopoulos, D. (2006) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988706286226 · Cited by 65 · see citing works
Self-citation
- Authors
- Rentzos, M., Michalopoulou, M., Nikolaou, C., Cambouri, C., Rombos, A., Dimitrakopoulos, A., & Vassilopoulos, D.
- Affiliations
- Eginition Hospital (GR)
- Corresponding author
- Rentzos, M.
- ORCID
- Vassilopoulos, D.
- Venue
- Journal of the Neurological Sciences
- Publisher
- Elsevier BV
- Published
- 2005-02
- Volume
- 228
- Issue
- 2
- Pages
- 129-135
- ISSN
- 0022-510X (ISSN-L)
- OpenAlex
- W1965919284
- Cited by
- 45
- References
- 73
- Citations by year
- 2025: 1 · 2024: 3 · 2022: 2 · 2021: 1 · 2020: 2 · 2018: 4 · 2017: 4 · 2016: 2 · 2015: 1 · 2014: 2 · 2013: 4 · 2012: 4
- FWCI
- 0.90
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of the Neurological Sciences (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Immunology and Allergy › Cell Adhesion Molecules Research
- Keywords
- soluble intercellular adhesion molecule-1, soluble E-selectin, Alzheimer's disease, amyotrophic lateral sclerosis, neurodegenerative diseases, endothelial activation, serum biomarkers, neuroinflammation, cytokines
- MeSH terms
- Adult, Aged, Aged, 80 and over, Alzheimer Disease, Amyotrophic Lateral Sclerosis, Cell Adhesion, Endothelium, Vascular, Enzyme-Linked Immunosorbent Assay, Female, Humans, Male, Middle Aged, Predictive Value of Tests, Solubility, Biomarkers, Cell Adhesion Molecules, Up-Regulation, Cytokines, Intercellular Adhesion Molecule-1, E-Selectin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
